Apoptosis and nitrative stress associated with phosphodiesterase inhibitor-induced mesenteric vasculitis in rats

Toxicol Pathol. 2003 Nov-Dec;31(6):638-45. doi: 10.1080/01926230390241972.

Abstract

Nitric oxide may play a role in phosphodiesterase (PDE) inhibitor-induced rat mesenteric vasculitis. The present study was conducted to identify cellular sources of iNOS, determine the distribution of nitrotyrosine (NT) residues as a footprint of peroxynitrite (ONOO-) production, and evaluate their association with vascular apoptosis. To dissociate primary events from secondary changes associated with the inflammatory response, rats were given the PDE IV inhibitor CI-1018 orally at 750 mg/kg alone or concurrently with dexamethasone (DEX) intraperitoneally at 1 mg/kg for 4-5 days. Neutrophil (PMN) involvement in apoptosis was investigated in CI-1018 treated rats dosed with rabbit anti-rat PMN serum (APS). iNOS expression, NT residues, and caspase-3 were detected by immuno-histochemistry. Apoptosis was evaluated by TUNEL assay. CI-1018 induced vascular lesions were associated with iNOS expression in endothelial cells and inflammatory infiltrates; NT was evident only in the latter. Caspase-3 and TUNEL-positive staining were prominent only in medial smooth muscle cells (SMC) from CI-1018-treated rats and only when associated with active inflammation. iNOS- and NT-positive inflammatory cells were present in close proximity to SMC with caspase-3 staining. Inflammatory infiltrates were absent in rats given DEX with minimal SMC necrosis and hemorrhage remained. DEX eliminated apoptosis and immunoreactivity associated with caspase-3, iNOS, and NT. APS depletion of PMNs decreased the incidence and severity of vasculitis but failed to abolish completely caspase-3 immunoreactivity. Expression patterns for caspase-3, iNOS, and NT demonstrated that nitrative stress is a prominent feature of PDE inhibitor-induced vasculitis, with a possible role in medial SMC apoptosis. Further, medial SMC apoptosis may not be a primary event, but instead may be secondary to the inflammatory response.

MeSH terms

  • Administration, Oral
  • Animals
  • Antilymphocyte Serum / immunology
  • Antilymphocyte Serum / pharmacology
  • Apoptosis / drug effects*
  • Caspase 3
  • Caspases / metabolism
  • Dexamethasone / administration & dosage
  • Dexamethasone / pharmacology
  • Drug Therapy, Combination
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / enzymology
  • Endothelium, Vascular / pathology
  • Female
  • Immunoenzyme Techniques
  • In Situ Nick-End Labeling
  • Injections, Intraperitoneal
  • Mesenteric Arteries / drug effects*
  • Mesenteric Arteries / metabolism
  • Mesenteric Arteries / pathology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism
  • Muscle, Smooth, Vascular / pathology
  • Neutrophils / drug effects
  • Neutrophils / immunology
  • Neutrophils / pathology
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type II
  • Oxidative Stress / drug effects*
  • Peroxynitrous Acid / metabolism*
  • Phosphodiesterase Inhibitors / administration & dosage
  • Phosphodiesterase Inhibitors / toxicity*
  • Rats
  • Rats, Wistar
  • Tyrosine / analogs & derivatives*
  • Tyrosine / metabolism
  • Vasculitis / chemically induced*
  • Vasculitis / metabolism
  • Vasculitis / pathology

Substances

  • Antilymphocyte Serum
  • Phosphodiesterase Inhibitors
  • Peroxynitrous Acid
  • 3-nitrotyrosine
  • Tyrosine
  • Dexamethasone
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Casp3 protein, rat
  • Caspase 3
  • Caspases